/Teleflex%20Incorporated%20sign%20at%20office-by%20Tada%20Images%20via%20Shutterstock.jpg)
Valued at a market cap of $11.4 billion, Teleflex Incorporated (TFX) is a leading provider of single-use medical devices for critical care and surgical procedures. The Pennsylvania-based company leverages its expertise in vascular access, interventional cardiology, anesthesia, and urology to maintain a strong market presence, serving a broad customer base.
Shares of this surgical equipment maker have underperformed the broader market over the past 52 weeks. TFX has risen 12.2% during this period, contrasting with the S&P 500 Index's ($SPX) robust rally of 26.1%. In 2024, TFX shares are down nearly 3%, compared to SPX's 17.2% gain on a YTD basis.